TITLE

Characterization of Health Related Quality of Life (HRQOL) for Patients With Functional Bowel Disorder (FBD) and Its Response to Treatment

AUTHOR(S)
Drossman, Douglas; Morris, Carolyn B.; Yuming Hu; Toner, Brenda B.; Diamant, Nicholas; Whitehead, William E.; Dalton, Christine B.; Leserman, Jane; Patrick, Donald L.; Bangdiwala, Shrikant I.
PUB. DATE
July 2007
SOURCE
American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1442
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND AND AIMS: Assessing health related quality of life (HRQOL) is becoming more important in research and clinical care. However, little information is available on the performance of HRQOL questionnaires for the functional bowel disorders (FBD). The aims of this study were to (a) understand the performance of the Sickness Impact Profile (SIP) and IBS-QOL for the functional bowel disorders at baseline and after treatment, (b) determine which HRQOL subscales best improve with treatment, (c) determine clinically meaningful improvement, and (d) determine the predictors of HRQOL at baseline and in response to treatment. METHODS: Women with moderate to severe FBD were evaluated using both medical (desipramine vs placebo) and psychological (cognitive-behavioral therapy vs education) treatments. Clinical and psychosocial questionnaires along with the SIP and IBS-QOL were given at baseline and after 12-wk treatment. RESULTS: (a) Patients with FBD experience functional limitations in social interactions, home management, and recreational activities, respond emotionally to the pain, feel helpless, out of control, depressed, and irritable, and perceive restrictions in lifestyle relating to toilet accessibility, and eating; (b) HRQOL is not different among the FBD diagnoses or IBS subgroups; (c) the IBS-QOL is more responsive to treatment than the SIP; (d) meaningful clinical improvement is 2.8 points for SIP and 14 for IBS-QOL; and (e) improvement is demonstrated primarily in psychosocial rather than physical domains. In addition, we found that expectation of benefit is greater for taking a pill over a psychological intervention, and the predictive effects of abuse history and pain on outcome is mediated by psychosocial factors. CONCLUSIONS: The data support the value of the IBS-QOL over the SIP, and provide new information on the profile of impairment in FBD, and the ways in which medical and psychological treatments produce improvement in HRQOL.
ACCESSION #
25489312

 

Related Articles

  • Cilansetron beneficial in IBS with diarrhoea predominance.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p13 

    Discusses research being done on the impact of cilansetron on the quality of life of patients with irritable bowel syndrome. Reference to a study by S. D. Levenson et al, published in the April 2005 issue of "Gastroenterology"; Assessment of the outcomes of the application of the drug;...

  • Fibromyalgia in the Irritable Bowel Syndrome: Studies of Prevalence and Clinical Implications. Sperber, A. D.; Atzmon, Y.; Neumann, L.; Weisberg, I.; Shalit, Y.; Abu-Shakrah, M.; Fich, A.; Buskila, D. // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3541 

    OBJECTIVE: The irritable bowel syndrome (IBS) and the fibromyalgia syndrome (FS) coexist in many patients. We conducted complementary studies of the prevalence of FS in IBS patients and matched controls, and of IBS in FS patients and the implications of concomitant IBS and FS on health-related...

  • Hypnotherapy has long-term beneficial effects in IBS.  // Nursing Standard;1/21/2004, Vol. 18 Issue 19, p10 

    Reports that hypnotherapy is a therapeutic option for the treatment of irritable bowel syndrome (IBS) in Great Britain. Relief of IBS symptoms in the short term; Quality of life; Anxiety.

  • Accurately Identifying Irritable Bowel Syndrome in the Female Client. Desmarais, Pamela L. // Clinical Excellence for Nurse Practitioners;Winter2005, Vol. 9 Issue 4, p186 

    Irritable bowel syndrome (IBS) prevalence in the United States is approximately one in five. The socioeconomic impact is seen in increased health care visits, absenteeism from work, and loss of social activities. The majority of patients with IBS are adult females who seek care from primary...

  • Irritable bowel syndrome: diagnosis and symptom management. Watson, Alan R.; Bowling, Timothy E. // British Journal of Community Nursing;Mar2005, Vol. 10 Issue 3, p118 

    Irritable bowel syndrome (IBS) is a very common problem affecting 10% of the population at some time. Its cause and pathogenesis, however, remain poorly understood. Diagnosis is usually straightforward and detailed investigations are only required when the presentation is atypical. Treating IBS...

  • APPLICABILITY OF SYMPTOM BASED DIAGNOSTIC CRITERIA TO PATIENTS WITH A FIRM DIAGNOSIS OF IBS MADE IN THE OUTPATIENT CLINIC SETTING.  // Gut;Apr2004 Supplement 3, Vol. 53, pA113 

    This article cites a study conducted to assess the sensitivity of the three commonly used criteria in patients who had been followed up for at least one year alter having been given a firm clinical diagnosis of irritable bowel syndrome (IBS) by an experienced physician with on interest in the...

  • Text messaging: an innovative method of data collection in medical research. Kew, S. T. // BMC Research Notes;2010, Vol. 3, p342 

    Background: The ubiquitous use of mobile phones in sending and receiving text messages has become a norm for young people. Undeniably, text messaging has become a new and important communication medium not only in the social realm but in education as well. The aim of this study is to evaluate...

  • Measuring Successful Treatment of Irritable Bowel Syndrome: Is “Satisfactory Relief ” Enough? Schoenfeld, Philip; Talley, Nicholas J. // American Journal of Gastroenterology;May2006, Vol. 101 Issue 5, p1066 

    The treatment options for the irritable bowel syndrome (IBS) are expanding as new therapies, including probiotics and serotonin receptor agents, become available. Before any new agents gain widespread use, they must be studied in appropriately designed clinical trials. Symptom improvement...

  • Characterization of the Alternating Bowel Habit Subtype in Patients with Irritable Bowel Syndrome. Tillisch, Kirsten; Labus, Jennifer S.; Naliboff, Bruce D.; Bolus, Roger; Shetzline, Michael; Mayer, Emeran A.; Chang, Lin // American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p896 

    BACKGROUND: Due to a wide range of symptom patterns, patients with irritable bowel syndrome (IBS) are often subgrouped by bowel habit. However, the IBS subgroup with alternating bowel habits (IBS-A) has been poorly characterized.OBJECTIVES: (i) To determine a set of bowel habit symptom criteria,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics